Followers | 439 |
Posts | 41282 |
Boards Moderated | 0 |
Alias Born | 10/07/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 19, 2012 7:52:04 PM
They have been producing and distributing Clotamin since 2008. This is not a new product.
http://ww2.gazette.net/stories/070208/bethnew213017_32358.shtml
Wednesday, July 2, 2008
Barch brothers love the taste of their own medicine
==============
HEALTHCARE DISTRIBUTION SPECIALISTS INC.
(formerly Amerisure Pharmaceuticals LLC)
(A Development Stage Company)
Consolidated Balance Sheets
(expressed in US dollars)
(unaudited)
----
Registrant:
Mackie Barch
10303 Montgomery Ave
Kensington, Maryland 20895
United States
Registered through: GoDaddy.com, LLC (http://www.godaddy.com)
Domain Name: AMERISUREPHARMA.COM
Created on: 18-Sep-08
Expires on: 18-Sep-12
Last Updated on: 19-Sep-10
Administrative Contact:
Barch, Mackie mackiebarch@gmail.com
10303 Montgomery Ave
Kensington, Maryland 20895
United States
+1.2022705404 Fax --
Technical Contact:
Barch, Mackie mackiebarch@gmail.com
10303 Montgomery Ave
Kensington, Maryland 20895
United States
+1.2022705404 Fax --
Domain servers in listed order:
NS29.DOMAINCONTROL.COM
NS30.DOMAINCONTROL.COM
------------
==============
And the SEC filed financials show a whole different picture - so tell me exactly how this company can be worth anywhere near a couple hundred MILLION dollars!
http://www.sec.gov/Archives/edgar/data/1470915/000107878212000480/f8k021612_ex99z1.htm
AMERISURE PHARMACEUTICALS LLC
(A Development Stage Company)
Notes to the Financial Statements
Year ended December 31, 2010
(Expressed in US dollars)
1.
Nature of Operations and Continuance of Business
Amerisure Pharmaceuticals LLC (the “Company”) was incorporated as a limited liability company in the state of Delaware on September 19, 2008. The Company is in the business of reselling pharmaceutical drugs to third party customers throughout the United States.
Going Concern
These financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. As at December 31, 2010, the Company has a working capital deficit of $6,133, and an accumulated deficit of $7,133. The continued operations of the Company are dependent on its ability to generate future cash flows or obtain additional financing. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company be unable to continue as a going concern.
-------------
http://www.sec.gov/Archives/edgar/data/1470915/000107878212000480/f8k021612_ex99z2.htm
HEALTHCARE DISTRIBUTION SPECIALISTS INC.
(formerly Amerisure Pharmaceuticals LLC)
(A Development Stage Company)
Notes to the Consolidated Financial Statements
September 30, 2011
(Expressed in US dollars)
(unaudited)
1.
Nature of Operations and Continuance of Business
Healthcare Distribution Specialists Inc. (the Company) was incorporated as a limited liability company in the state of Delaware on September 19, 2008 under the name Amerisure Pharmaceuticals LLC. During the period ended September 30, 2011, the Company changed its name to Healthcare Distribution Specialists Inc. The Company is in the business of reselling pharmaceutical drugs to third party customers throughout the United States. On August 1, 2011, the Company entered into an acquisition agreement with Global Nutritional Research, a manufacturer and distributor of the vitamin Clotamin®.
Going Concern
These financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. As at September 30, 2011, the Company has a working capital deficit of $388,337, and an accumulated deficit of $238,530. The continued operations of the Company are dependent on its ability to generate future cash flows or obtain additional financing. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recorded assets or liabilities that might be necessary should the Company be unable to continue as a going concern.
From substantial doubt to a market cap of hundreds of MILLIONS of dollar - no wonder the FINRA has commenced an inquiry!
Recent PHRX News
- Specialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade Cocaine • AllPennyStocks.com • 05/23/2024 04:34:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM